Quantcast

Cook County News

COOK COUNTY RECORD

Tuesday, April 1, 2025

Simmons Hanly Conroy LLP

Recent News About Simmons Hanly Conroy LLP

  • Report: Political donations from trial lawyers topped $35 million in 15 years

    By Ann Maher and Jonathan Bilyk |
    A new study published by the Illinois Civil Justice League shows that campaign contributions from trial lawyers to Illinois politicians and judges topped $35.25 million during the past 15 years. The courts in Cook County, along with those in downstate Madison and St. Clair counties, near St. Louis, host the state’s highest concentrations of civil litigation, factor prominently in "Justice for Sale III," a report analyzing campaign contributions made by the plaintiffs' bar and the profound impact

  • Questions raised over number of defendant companies named in asbestos suits; can number in hundreds

    By Jessica Karmasek |
    The average number of companies targeted by some of the biggest asbestos firms in their lawsuits is in the triple-figures, according to recent statistics, forcing some, especially those in claims management, to question the strategy of plaintiffs’ lawyers.

  • Chicago red light plaintiffs want another try, attack 'convenient' dismissal as legally flawed

    By Jonathan Bilyk |
    The plaintiffs behind what a judge called a “Herculean challenge” to the city of Chicago’s red light camera program have returned to Cook County court, saying they deserve another shot at arguing their case because a Cook County judge who dismissed their case in April not only erred, but in the process “ended up creating brand-new ‘rules’ of Illinois law.” On May 2, a group of plaintiffs led by named plaintiff Terie Kata, filed a motion to reconsider their class action lawsuit against the city o

  • Judge tosses insurers' RICO class action vs testosterone drug makers, saying not specific enough

    By Jonathan Bilyk |
    A federal judge has tossed, with leave to amend, the bulk of a federal racketeering and fraud class action brought by an Ohio-based health insurer against Abbvie and other makers of testosterone drugs, saying the insurer has not yet backed up with enough particularity its allegations the drugmakers invented the condition known as “low T,” and, through false marketing to doctors, patients and insurers alike, induced insurers and others to pay far more for the drugs to treat the condition.